TRANSFORMING DIALYSIS SAFETY KIDNEY HEALTH INITIATIVE KIDNEYX DONATE COMMUNITIES MY ASN LOGIN EDUCATION TRAINING PUBS ADVOCACY GRANTS MEMBERS MORE... MEMBERSHIP Renew Your Membership Renew your membership now for 2022, and maintain all of the great ASN benefits. RENEW NOW AMERICAN SOCIETY OF NEPHROLOGY A WORLD WITHOUT KIDNEY DISEASES ASN represents more than 21,000 kidney health professionals working to help people with kidney diseases and their families. Created with input from all of ASN's constituencies, the new ASN logo allows the society to continue our growth and work toward a goal of a world without kidney diseases. ALLIANCE REGISTER THROUGH DECEMBER 31 | KIDNEY WEEK 2021 RENEW YOUR ASN MEMBERSHIP FOR 2022 BE A PART OF ASN Renew your membership for 2022, and maintain all of your great ASN member benefits, including journal subscriptions, educational discounts, networking opportunities, and more. READ MORE REGISTRATION IS STILL OPEN FOR KIDNEY WEEK KIDNEY WEEK 2021 Missed Kidney Week? Registration is still open through December 31st, and you can still access all content on-demand, including Early Programs and the Annual Meeting, from any device. READ MORE BUILDING AWARENESS: WE'RE UNITED 4 KIDNEY HEALTH JOIN THE MOVEMENT "We're United 4 Kidney Health" is an awareness-building campaign that captures our goal of embracing early intervention and advocating for kidney health. READ MORE Latest nephSAP: August 2021 The latest Nephrology Self-Assessment Program (nephSAP) issue, Volume 20: Issue 1 (Aug 2021): End-Stage Kidney Disease is now available online. VIEW ISSUE KHI RRT Product Terminology Fact Sheet Defining Common Renal Replacement Therapy (RRT) Terminology KHI Prize Competitions Prize competitions are a method of problem-solving that describes a problem (usually to the general public) and offers a prize or prizes to whoever comes up with the best soluti... KidneyX Online Learning Modules NTDS: A Curriculum to Achieve Zero Preventable Infections Managing Infections in an Outpatient Dialysis Facility These self-paced learning tools are designed specifically fo... NTDS Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors JASN | Friday, October 29 @ 3:45 PM RE: TOLVAPTAN FOR PCKD WITH LIVER CYSTS 33 MINUTES AGO Dr. Hirsch is always insightful. I hoping that Kadmon or Reata gets their drugs approved soon. The Kadmon Drug is based on concrete science whi... VIEW DISCUSSION FRIDAY, NOVEMBER 05, 2021 @ 11:00 AM During today's plenary session at Kidney Week 2021, ASN President Susan E. Quaggin, MD, FASN, announced the Barbara T. Murphy Endowe... READ MORE CATALYZE INNOVATION AND TREATMENT CONNECT WITH ASN CONTACT Sitemap Terms RSS Technical Support © American Society of Nephrology